Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing the efficacy and safety of hydroquinone 4% cream with versus without a fractional picosecond 1,064 nm laser for dermal or mix…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroquinone 4% cream (hydroquinone)

Snippet

Sponsor: Mae Fah Luang University Hospital | Conditions: Picoseconds Laser, Melasma | Phase 2 | Status: COMPLETED